Stay updated with breaking news from Key Activities. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the third quarter ended September 30, 2021. "Our third...
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Catalyst Pharmaceuticals Announces First Quarter 2021 Financial Results and Provides Business Update Catalyst Pharmaceuticals, Inc.May 10, 2021 GMT -Firdapse® Q1 2021 Net Revenues of $30.2 Million -First Quarter 2021 GAAP Net Income of $7.7 Million; Non-GAAP Net Income of $11.6 Million -Recently Received Orphan Drug Designation for Firdapse® in Japan -$143.3 Million in Cash and Investments and no Funded Debt at end of Q1-2021 -Catalyst to Host Quarterly Conference Call at 8:30 AM ET Tomorrow CORAL...